type: position_score
table:
  filename: ENCFF849QFO.tabix.bed.gz
  header_mode: none
  zero_based: true
  format: tabix
  chrom:
    column_index: 0
  pos_begin:
    column_index: 1
  pos_end:
    column_index: 2
scores:
- id: DNase-seq_ENCSR365CUB
  column_index: 3
  type: float
  desc: 'DNase-seq ENCSR365CUB [biosample_summary="Homo sapiens activated CD4-positive, alpha-beta T cell male adult (35 years) treated with 10 ng/mL Interleukin-2 for 14 days, anti-CD3 and anti-CD28 coated beads for 24 hours, anti-CD3 and anti-CD28 coated beads for 14 days"]'
  histogram:
    type: number
    number_of_bins: 100
meta:
  summary: 'DNase-seq ENCSR365CUB [biosample_summary="Homo sapiens activated CD4-positive, alpha-beta T cell male adult (35 years) treated with 10 ng/mL Interleukin-2 for 14 days, anti-CD3 and anti-CD28 coated beads for 24 hours, anti-CD3 and anti-CD28 coated beads for 14 days"]'
  description: '**status**: released


    **biological\_replicates**: Rep 1


    **summary**: male adult (35 years) treated with 10 ng/mL Interleukin-2 for 14
    days, anti-CD3 and anti-CD28 coated beads for 24 hours, anti-CD3 and anti-CD28
    coated beads for 14 days


    **output\_type**: peaks


    '
  labels:
    reference_genome: hg38/genomes/GRCh38-hg38
    accession: ENCSR365CUB
    status: released
    assay_term_name: DNase-seq
    simple_biosample_summary: male adult (35 years) treated with 10 ng/mL Interleukin-2
      for 14 days, anti-CD3 and anti-CD28 coated beads for 24 hours, anti-CD3 and
      anti-CD28 coated beads for 14 days
    biosample_summary: Homo sapiens activated CD4-positive, alpha-beta T cell male
      adult (35 years) treated with 10 ng/mL Interleukin-2 for 14 days, anti-CD3 and
      anti-CD28 coated beads for 24 hours, anti-CD3 and anti-CD28 coated beads for
      14 days
    replication_type: unreplicated
    biosample_ontology: /biosample-types/primary_cell_CL_0000896/
    perturbed: false
    doi: 10.17989/ENCSR365CUB
    date_created: '2021-09-29T23:48:43.431703+00:00'
    date_released: '2022-03-01'
    submitter_comment: ''